FR2366570A1 - Procede et reactifs de dosage immunochimique par un anticorps marque - Google Patents

Procede et reactifs de dosage immunochimique par un anticorps marque

Info

Publication number
FR2366570A1
FR2366570A1 FR7729501A FR7729501A FR2366570A1 FR 2366570 A1 FR2366570 A1 FR 2366570A1 FR 7729501 A FR7729501 A FR 7729501A FR 7729501 A FR7729501 A FR 7729501A FR 2366570 A1 FR2366570 A1 FR 2366570A1
Authority
FR
France
Prior art keywords
antibody
antigen
brand
reagents
immunochemical assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7729501A
Other languages
English (en)
French (fr)
Other versions
FR2366570B1 (cg-RX-API-DMAC7.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of FR2366570A1 publication Critical patent/FR2366570A1/fr
Application granted granted Critical
Publication of FR2366570B1 publication Critical patent/FR2366570B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7729501A 1976-09-30 1977-09-30 Procede et reactifs de dosage immunochimique par un anticorps marque Granted FR2366570A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11762176A JPS5344622A (en) 1976-09-30 1976-09-30 Immunologically measuring method

Publications (2)

Publication Number Publication Date
FR2366570A1 true FR2366570A1 (fr) 1978-04-28
FR2366570B1 FR2366570B1 (cg-RX-API-DMAC7.html) 1981-11-27

Family

ID=14716274

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7729501A Granted FR2366570A1 (fr) 1976-09-30 1977-09-30 Procede et reactifs de dosage immunochimique par un anticorps marque

Country Status (6)

Country Link
US (1) US4200436A (cg-RX-API-DMAC7.html)
JP (1) JPS5344622A (cg-RX-API-DMAC7.html)
DE (1) DE2743444C3 (cg-RX-API-DMAC7.html)
FR (1) FR2366570A1 (cg-RX-API-DMAC7.html)
GB (1) GB1550320A (cg-RX-API-DMAC7.html)
NL (1) NL7710585A (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0161107A3 (en) * 1984-05-08 1986-12-10 Farmos-Yhtyma Oy Immunometric method for the determination of a hapten

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2013211B (en) * 1978-01-26 1982-06-30 Technicon Instr Immunoassays using f(ab')2 fragments
IL56342A (en) * 1978-12-29 1982-05-31 Zer Tamar Method and means for determining human chorionic gonadotropin in urine
DE2908053C2 (de) * 1979-03-02 1982-08-19 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Reagenz zur Bestimmung der Creatinkinase MB
US4446231A (en) * 1979-10-03 1984-05-01 Self Colin H Immunoassay using an amplified cyclic detection system
GB2059421A (en) * 1979-10-03 1981-04-23 Self C H Assay method and reagents therefor
NL8000173A (nl) * 1980-01-11 1981-08-03 Akzo Nv Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen.
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
AU543007B2 (en) * 1980-04-15 1985-03-28 Technicon Instruments Corportion Agglutination immunoassay
US4361647A (en) * 1980-05-22 1982-11-30 Palo Alto Medical Research Foundation Sandwich immunoassay and compositions for use therein
DE3174064D1 (en) * 1980-10-15 1986-04-17 Takeda Chemical Industries Ltd Method for immunochemical assay and kit therefor
JPS585659A (ja) * 1981-06-24 1983-01-13 ハイブリテツク　インコ−ポレ−テツド 単クロ−ン性抗体を使用する免疫学的、抑制試験
US4588680A (en) * 1981-07-31 1986-05-13 Mount Sinai School Of Medicine Of The City University Of New York Assay for viruses
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
US4446232A (en) * 1981-10-13 1984-05-01 Liotta Lance A Enzyme immunoassay with two-zoned device having bound antigens
US4444878A (en) * 1981-12-21 1984-04-24 Boston Biomedical Research Institute, Inc. Bispecific antibody determinants
WO1983003306A1 (en) * 1982-03-19 1983-09-29 Roger Philip Ekins Method and composition for free ligand assays
US5304498A (en) * 1982-03-19 1994-04-19 Ekins Roger Philip Method and composition for free ligand assay
US4483929A (en) * 1982-05-03 1984-11-20 Liposome Technology Incorporated Liposomes with glycolipid-linked antibodies
DE3225027A1 (de) * 1982-07-05 1984-01-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren
US4666866A (en) * 1983-04-19 1987-05-19 Krauth Gary H Immunoassay for antigens employing supported binder
DE3327642A1 (de) * 1983-07-30 1985-02-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung eines partners einer immunreaktion sowie reagens zur durchfuehrung dieses verfahrens
DE3331627A1 (de) * 1983-09-01 1985-03-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur immunologischen bestimmung fuer proteine in koerperfluessigkeiten, unter verwendung monovalenter antikoerperfragmente
US4551426A (en) * 1983-10-03 1985-11-05 E. I. Du Pont De Nemours And Company Heterogeneous immunoassay for digoxin using ouabain as a separation means
DE3430905A1 (de) * 1984-08-22 1986-02-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung einer immunologisch bindefaehigen substanz
DE3433652A1 (de) * 1984-09-13 1986-03-20 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren fuer haptene und proteine
US4657853A (en) * 1984-09-14 1987-04-14 E. I. Du Pont De Nemours And Company Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
US5501949A (en) * 1985-12-10 1996-03-26 Murex Diagnostics Corporation Particle bound binding component immunoassay
US5236826A (en) * 1985-12-10 1993-08-17 Murex Corporation Immunoassay for the detection or quantitation of an analyte
WO1987003690A1 (en) * 1985-12-10 1987-06-18 Murex Corporation Particle-bound binding component immunoassay
EP0312543A4 (en) * 1986-07-03 1990-12-27 Scripps Clinic And Research Foundation _i(in situ) active compound assembly
US5177083A (en) * 1986-07-03 1993-01-05 The Scripps Clinic And Research Foundation Drugs effective against retroviruses
US4812449A (en) * 1986-07-03 1989-03-14 Scripps Clinic And Research Foundation In situ active compound assembly
US5229268A (en) * 1986-07-14 1993-07-20 Abbott Laboratories Method for diagnostic immunoassay by solid phase separation
US4788136A (en) * 1987-04-07 1988-11-29 Abbott Laboratories Diagnostic immunoassay by solid phase separation for digoxin
US5003054A (en) * 1987-04-07 1991-03-26 Abbott Laboratories Ouabain triacetate derivative compounds
US4971904A (en) * 1987-06-26 1990-11-20 E. I. Du Pont De Nemours And Company Heterogeneous immunoassay
US5009998A (en) * 1987-06-26 1991-04-23 E. I. Du Pont De Nemours And Company Method for performing heterogeneous immunoassay
US5086002A (en) * 1987-09-07 1992-02-04 Agen Biomedical, Ltd. Erythrocyte agglutination assay
US4983529A (en) * 1988-06-10 1991-01-08 Abbott Laboratories Immunoassay for HIV-I antigens using F(AB')2 fragments as probe
US5045480A (en) * 1989-02-09 1991-09-03 Miles Inc. Gel particles having hapten moieties bound thereto as immunoassay reagent
US5583003A (en) * 1989-09-25 1996-12-10 Agen Limited Agglutination assay
JPH04363659A (ja) * 1991-06-10 1992-12-16 Smithkline Beckman Corp ビタミンｂ１２の分析
WO1994009773A1 (en) * 1992-10-26 1994-05-11 The Scripps Research Institute New antiviral agents
WO1995017673A1 (en) * 1993-12-21 1995-06-29 Ocutech, Inc. Ocular diagnostics and therapies
US5795784A (en) 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
US5856194A (en) 1996-09-19 1999-01-05 Abbott Laboratories Method for determination of item of interest in a sample
US5977319A (en) * 1996-10-21 1999-11-02 Cambridge Antibody Technology Limited Specific binding members for estradiol; materials and methods
US7341837B2 (en) * 2003-09-02 2008-03-11 Lawton Robert L Soluble analyte detection and amplification
EP1893241A2 (en) * 2005-04-28 2008-03-05 Ventana Medical Systems, Inc. Fluorescent nanoparticles conjugated to antibodies via a peg linker
EP1877101B1 (en) * 2005-04-28 2016-11-16 Ventana Medical Systems, Inc. Enzymes conjugated to antibodies via a peg heterobifuctional linker
JP4699840B2 (ja) * 2005-08-31 2011-06-15 ローム株式会社 バイオチップ及び免疫分析方法
EP1951316B1 (en) * 2005-11-23 2015-08-19 Ventana Medical Systems, Inc. Molecular conjugate
JP5416263B2 (ja) * 2011-09-26 2014-02-12 富士フイルム株式会社 蛍光粒子を用いたコルチゾール免疫アッセイ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
US4002532A (en) * 1974-10-21 1977-01-11 Weltman Joel K Enzyme conjugates
US3992516A (en) * 1974-10-30 1976-11-16 Sook Kyung Lim Direct fluorescent antibody composition and method for P. Pneumocystis carinii
US4067959A (en) * 1976-05-10 1978-01-10 International Diagnostic Technology, Inc. Indirect solid surface test for antigens or antibodies

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EXBK/74 *
EXBK/76 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0161107A3 (en) * 1984-05-08 1986-12-10 Farmos-Yhtyma Oy Immunometric method for the determination of a hapten

Also Published As

Publication number Publication date
GB1550320A (en) 1979-08-08
DE2743444B2 (de) 1980-12-04
JPS5344622A (en) 1978-04-21
NL7710585A (nl) 1978-04-03
DE2743444C3 (de) 1984-09-13
US4200436A (en) 1980-04-29
DE2743444A1 (de) 1978-04-06
FR2366570B1 (cg-RX-API-DMAC7.html) 1981-11-27

Similar Documents

Publication Publication Date Title
FR2366570A1 (fr) Procede et reactifs de dosage immunochimique par un anticorps marque
FR2367286A1 (fr) Nouveau procede et reactifs de dosage immunochimique de substances physiologiquement actives
GB1327545A (en) Barbituric acid antigens antibodies therefor and a method of assay of barbituric acid derivatives
SE8200978L (sv) Forfarande och medel for immunologisk analys
NZ191317A (en) Immunological determination of immuno-complexes diagnostic agent
DK165785D0 (da) Immunometrisk bestemmelse rettet mod flere steder
NZ237535A (en) Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody
JPS6428560A (en) Immunometric measurement
FR2392386A1 (fr) Procede pour determiner la presence d'antigenes, d'anticorps et de complexes antigene-anticorps dans les liquides
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
FR2363793A1 (fr) Nouveau procede de dosage d'antigenes et d'anticorps, selon la technique immunologique avec enzyme fixee
EP0368273A3 (en) New method of assay for antigen
PT733903E (pt) Processo de dosagem imunologica de cortisol nomeadamente urinario e reagentes utilizados
FR2435040A1 (fr) Composition pour determiner l'immunoglobuline g humaine, procede pour sa preparation et son emploi
EP0158291A3 (en) A method for purifying carcinoembryonic antigen and a method for producing a carcinoembryonic antigen-reactive monoclonal antibody
NL194961B (nl) Compositie omvattende een component die in staat is tot reactie met Pseudomonas aeruginosa flagella, farmaceutisch preparaat, cellijn, monoklonaal antilichaam, werkwijze ter bepaling van Pseudomonas aeruginosa, alsmede pakket voor het detecteren daarvan.
ES2033834T3 (es) Un metodo para determinar alteraciones de la gestion.
EP0419367B1 (fr) Procédé de détection d'une substance biologique à l'aide de ligands
ES552704A0 (es) Procedimiento para la obtencion de un anticuerpo monoclonal contra la hormona luteinizante
FI91976C (fi) Menetelmä ja reagenssi follikkelia stimuloivan hormonin määrittämiseksi sekä tähän tarkoitukseen sopivat monoklonaaliset vasta-aineet
GB2109931A (en) Enzyme immunoassay
ES8401261A1 (es) Soportes de materia plastica revestidos de un segundo anticuerpo.
SE8401424L (sv) Sett att bestemma immunkomplex specifika mot tumor-associerad antigen
FR2364447A1 (fr) Procede de dosage d'antigenes et d'anticorps selon la technique immunologique avec enzyme fixee notamment sur support de silicone
EP0173973A3 (en) Method for the determination of thyroid-stimulating hormone